{'text': 'Why Pfizer is abandoning its OTC Lipitor program', 'publisher': {'href': 'https://www.biopharmadive.com', 'title': 'BioPharma Dive'}, 'created_at': 'Thu, 30 Jul 2015 07:00:00 GMT', 'description': 'Why Pfizer is abandoning its OTC Lipitor program  BioPharma Dive', 'url': 'https://news.google.com/rss/articles/CBMilgFBVV95cUxNRlJWTGZOSEY2U2hxa2RFSXdLWHdLX2t1MHZXYXpSSVR2Tm9BMUZYcjJrcDNLbU5taWV1ZTJqWG1xMk05UVBFQ2g1S0xxN1F0SUxSUDRlbUk3d2VSMmJsbjdZY2dVejBUSDVYcjRXWGxyVEVCdkl6cm1WUW5wUW5zWlo5ZzFfZVpYSFBQWVpGX3pXakdzdlE?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': "There's a whole hierarchy to dressing on Wall Street", 'publisher': {'href': 'https://finance.yahoo.com', 'title': 'Yahoo Finance'}, 'created_at': 'Thu, 30 Jul 2015 07:00:00 GMT', 'description': "There's a whole hierarchy to dressing on Wall Street  Yahoo Finance", 'url': 'https://news.google.com/rss/articles/CBMiigFBVV95cUxNWkxWSjJybTU4bUhnWnIzaWtJN0dxak1XZnJOUXh4Rmwzdkotc2FYbGF1V2JNbEg3U2tOQy1KTHlMYmg3cW4xTDVubzNPeFl5U19PdmdoWVpQU1prbEliOVdXMGtBQ3R3OEUwUVFIcmdBRE1kTENWSFlhcTZrRGt3dlg0RXhrOFRpU2c?oc=5&hl=en-US&gl=US&ceid=US:en'}
